Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 293, Issue 5, 2007, Pages

  Tang, Jen Ruey ^a   Seedorf, Gregory ^a   Balasubramaniam, Vivek ^a   Maxey, Anne ^a   Markham, Neil ^a   Abman, Steven H ^a  

^a CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

Alveolar growth; Bronchopulmonary dysplasia; Developing lung; Vascular growth

Indexed keywords

CASPASE 3; NITRIC OXIDE; SEMAXANIB; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; LUNG ALVEOLUS CELL; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SINGLE DRUG DOSE;

ADMINISTRATION, INHALATION; ANGIOGENESIS INHIBITORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; INDOLES; LUNG; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PREGNANCY; PROTEIN-TYROSINE KINASES; PULMONARY ALVEOLI; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 36349035629     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00224.2007     Document Type: Article

References (44)

1. Adamson IY. Relationship of mesenchymal changes to alveolar epithelial cell differentiation in fetal rat lung. Anat Embryol 185: 275-280, 1992.
2. Afshar S, Gibson LL, Yuhanna1 IS, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC, Shaul PW. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 284: L749-L758, 2003.
3. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1: 1024-1028, 1995.
4. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH. Hyperoxia reduces bone marrow, circulating and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292: L1073-L1084, 2007.
5. Ballard RA, Truog W, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355: 343-353, 2006.
6. Bhatt AJ, Pryhuber GS, Huyck H, Watkins Metlay LA RH, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 1971-1980, 2001.
7. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 172: 899-906, 2005.
8. Bland RD, Xu L, Ertsey R, Rabinovitch M, Albertine KH, Wynn KA, Kumar VH, Ryan RM, Swartz DD, Csiszar K, Fong KSK. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 292: L1370-L1384, 2007.
9. Brown KR, England KM, Goss KL, Snyder JM, Acarregui MJ. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 281: L1001-L1010, 2001.
10. Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 1-postnatal lung growth. Thorax 37: 572-579, 1982.
11. Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 2-intrauterine and early postnatal lung growth. Thorax 37: 580-583, 1982.
12. DeMeester SL, Qiu Y, Buchman T, Hotchkiss RS, Dunnigan K, Karl IE, Cobb JP. Nitric oxide inhibits stress-induced endothelial cell apoptosis. Crit Care Med 269: 1500-1509, 1998.
13. Ferrara N and Davis-Smith T. The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
14. Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins BCL-2 and A1 in vascular endothelial cells. J Biol Chem 273: 13313-13316, 1998.
15. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′27-kinase/Akt signal transduction pathway: requirement for Flr/KDR activation. J Biol Chem 273: 30336-30343, 1998.
16. Hargitai B, Szabo V, Hajdu J, Harmath A, Pataki M, Farid P, Papp Z, Szende B. Apoptosis in various organs of preterm infants: histopathologic study of lung, kidney, liver, and brain of ventilated infants. Pediatr Res 50: 110-114, 2001.
17. Howlett CE, Hutchison JS, Veinot JP, Chiu A, Merchant P, Fliss H. Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. Am J Physiol Lung Cell Mol Physiol 277: L596-L605, 1999.
18. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
19. Kallapur SG, Bachurski CJ, Le Cras TD, Joshi SN, Ikegami M, Jobe AH. Vascular changes after intra-amniotic endotoxin in premature lamb lung. Am J Physiol Lung Cell Mol Physiol 287: L1178-L1185, 2004.
20. Kasahara Y, Tuder RM, Laimute TS, Le Cras TD, Abman SH, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106: 1311-1319, 2000.
21. Klekamp JG, Jarzecka K, Perkett EA. Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. Am J Pathol 154: 823-831, 1999.
22. Kinsella JP, Cutter GR, Walsh WF, Dale R. Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355: 354-364, 2006.
23. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 289: L529-L535, 2005.
24. Lassus P, Turanlahti M, Heikila P, Andersson LC, Nupponen I, Sarnesto A, Anderson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164: 1981-1987, 2001.
25. Le Cras TD, Makham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562, 2002.
26. Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240: 419-244, 1997.
27. Lin YJ, Markham NE, Balasubramanim V, Tang JR, Maxey A, Kinsella J, Abman SH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58: 22-29, 2005.
28. Lukkarinen HP, Laine J, Kaapa P. Lung epithelial cells undergo apoptosis in neonatal respiratory distress syndrome. Pediatr Res 53: 254-259, 2003.
29. MacRitchie AN, Albertine KH, Sun J, Lei PS, Jensen SC, Freestone AA, Clair PM, Dahl MJ, Godfrey EA, Carlton DP, Bland RD. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol 281: L1011-L1020, 2001.
30. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 16: 557-567, 1997.
31. Maniscalco WM, Watkins RH, Pryhuber S, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vasculature: development and alteration by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 282: L811-L823, 2002.
32. May M, Strobel P, Preisshofen T, Seidenspinner S, Marx A, Speer CP. Apoptosis and proliferation in lungs of ventilated and oxygen-treated preterm infants. Eur Respir J 23: 113-121, 2004.
33. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Kurt H, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Peter Grubb PH H, Shaul PW. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288: L450-L459, 2005.
34. McGrath-Morrow SA, Cho C, Cho C, Zhen L, Hicklin DJ, Tuder RM. Vascular endothelial growth factor receptor 2 blockade disrupts postnatal lung development. Am J Respir Cell Mol Biol 32: 420-427, 2005.
35. Rendas A, Brqanthwaite M, Lennox S, Reid L. Response of the pulmonary circulation to acute hypoxia in the growing pig. J Appl Physiol 52: 811-814, 1982.
36. Schreiber MD, Gin-Mestan K, Marks JD, Dezheng Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349: 2099-2107, 2003.
37. Schwarz MA, Wan Z, Liu J, Lee MK. Epithelial-mesenchymal interactions are linked to neovascularization. Am J Respir Cell Biol 30: 784-792, 2004.
38. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, Abman SH. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287: L344-L351, 2004.
39. Tang K, Rossiter HB, Wagner PD, Breen EC. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 97: 1559-1566, 2004.
40. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, McMahon G, Waltenberger J, Voelkel NF, Tuder RM. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 15: 427-438, 2001.
41. Thébaud B, Abman SH. Bronchopulmonary dysplasia-Where have all the vessels gone? Am J Respir Crit Care Med 175: 978-985, 2007.
42. Thébaud B, Ladha F, Michelakis ED, Monika Sawicka M, Thurston G, Farah Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, Archer SL. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112: 2477-2486, 2005.
43. Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, Kerbel RS. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264: 781-788, 1999.
44. Zhao L, Wang K, Ferrara N, Vu TH. Vascular endothelia growth factor coordinates proper development of lung epithelium and vasculature. Mech Dev 122: 877-886, 2005.